These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8244821)

  • 21. Primary treatment of childhood acute lymphoblastic leukemia of non-T cell lineage (including infants).
    Gaynon PS
    Hematol Oncol Clin North Am; 1990 Oct; 4(5):915-36. PubMed ID: 2262485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients.
    Uckun FM; Kersey JH; Gajl-Peczalska KJ; Heerema NA; Provisor AJ; Haag D; Gilchrist G; Song CW; Arthur DC; Roloff J
    J Clin Invest; 1987 Sep; 80(3):639-46. PubMed ID: 3497949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
    Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
    Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts.
    Ashley DM; Bol SJ; Kannourakis G
    Leuk Res; 1994 May; 18(5):337-46. PubMed ID: 8182924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology Group.
    Imbach P; Fuchs A; Berchtold W; Arnet B; Stupnicki A; Angst R; Signer E
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):346-9. PubMed ID: 7583392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute lymphoblastic leukemia blast cells do not inhibit bone marrow hematopoietic progenitor colony formation.
    Estrov Z; Freedman MH
    Exp Hematol; 1991 Mar; 19(3):221-5. PubMed ID: 1995313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.
    Panetta JC; Yanishevski Y; Pui CH; Sandlund JT; Rubnitz J; Rivera GK; Ribeiro R; Evans WE; Relling MV
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):419-28. PubMed ID: 12439601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
    Kearns PR; Pieters R; Rottier MM; Pearson AD; Hall AG
    Blood; 2001 Jan; 97(2):393-8. PubMed ID: 11154214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on the radiation sensitivity of normal versus leukemic bone marrow progenitor cell populations.
    Waddick KG; Chandan-Langlie M; Uckun FM
    Leuk Lymphoma; 1997 Mar; 25(1-2):77-90. PubMed ID: 9130616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
    Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia.
    Manabe A; Yi T; Kumagai M; Campana D
    Leukemia; 1993 Dec; 7(12):1990-5. PubMed ID: 8255098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
    Thyss A; Suciu S; Bertrand Y; Mazingue F; Robert A; Vilmer E; Mechinaud F; Benoit Y; Brock P; Ferster A; Lutz P; Boutard P; Marguerite G; Plouvier E; Michel G; Plantaz D; Munzer M; Rialland X; Chantraine JM; Norton L; Solbu G; Philippe N; Otten J
    J Clin Oncol; 1997 May; 15(5):1824-30. PubMed ID: 9164191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
    Gilchrist GS; Tubergen DG; Sather HN; Coccia PF; O'Brien RT; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1994 Dec; 12(12):2594-600. PubMed ID: 7989934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.